Other
Remainder of 2026
Biogen Remainder of 2026 increased by 207.7% to $400.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $350.00M to $400.00M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2016
Last reportedQ1 2026
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_6aa235Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $110.00M | $70.00M | $200.00M | $130.00M | $55.00M | $165.00M | $110.00M | $75.00M | $265.00M | $185.00M | $125.00M | $350.00M | $240.00M | $130.00M | $400.00M |
| QoQ Change | — | -36.4% | +185.7% | -35.0% | -57.7% | +200.0% | -33.3% | -31.8% | +253.3% | -30.2% | -32.4% | +180.0% | -31.4% | -45.8% | +207.7% |
| YoY Change | — | — | — | +18.2% | -21.4% | -17.5% | -15.4% | +36.4% | +60.6% | +68.2% | +66.7% | +32.1% | +29.7% | +4.0% | +14.3% |
Range$55.00M – $400.00M
CAGR+44.6%
Avg YoY Growth+23.0%
Median YoY Growth+24.0%
Remainder of 2026 at Other Companies
Frequently Asked Questions
- What is Biogen's remainder of 2026?
- Biogen (BIIB) reported remainder of 2026 of $400.00M in Q1 2026.
- How has Biogen's remainder of 2026 changed year-over-year?
- Biogen's remainder of 2026 increased by 14.3% year-over-year, from $350.00M to $400.00M.